Le Lézard
Classified in: Health

Innovation in Emergency Room Care is Noted on an Episode of "Behind The Scenes" with Laurence Fishburne


MIAMI, Sept. 22, 2019 /PRNewswire-PRWeb/ -- Noted actor Laurence Fishburne is using his performance skills and gravitas for informative purposes as host of the television show "Behind the Scenes". This educational show aims to help its audience understand the challenges facing society today and how technological innovations help alleviate these problems. One of the latest episodes takes a look at the changing landscape of emergency room care. "Behind the Scenes" takes a look at the latest technology helping emergency room workers save lives.

Emergency room care has always been important to communities, and also holds a cultural significance in society. Everything from television medical dramas to the nightly news features the emergency room. Meanwhile, doctors and researchers the world over have been working tirelessly to advance how emergency room workers improve patient protocols and help care for patients better. This latest episode of "Behind the Scenes" takes a look at these innovations and how our approach to emergency care is being advanced by innovation. The segment will feature innovators in the ER sector and physicians who are helping promote positive change.

"Behind the Scenes" features information from experts in their field and presents cutting edge information. The show has been celebrated by critics and has received awards for its educational content.

 

SOURCE Behind The Scenes with Laurence Fishburne


These press releases may also interest you

at 02:39
Third quarter    Net sales increased by 13% to SEK 24,034 M (21,191), with organic growth of 4% (5) and acquired net growth of 4% (2) Strong growth in Global Technologies and Americas and good growth in EMEA and Entrance Systems, while sales...

at 02:19
Isofol Medical AB (publ), , today announced the successful completion of Japan's Pharmaceutical and Medical Devices Agency (PMDA) review of the Clinical Trial Notification (CTN), allowing the start of the pivotal Phase 3 AGENT clinical study in...

at 02:11
"We continue to show strong organic sales growth and improved margins in the third quarter", says Mattias Perjos, President & CEO at Getinge. "The underlying cash flow remains strong despite that we seasonally are tying up more capital in the third...

at 01:54
UCB (Euronext Brussels: UCB) and Amgen today announced that following a re-examination procedure, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), has adopted a positive opinion recommending Marketing...

at 01:43
Reference is made to the stock exchange release from Nordic Nanovector ASA (OSE: NANO) ("Nordic Nanovector" or the "Company"), a biopharmaceutical company dedicated to extending and improving the lives of patients with haematological cancers through...

at 01:00
Amgen and UCB (Euronext Brussels: UCB) today announced that following a re-examination procedure, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending Marketing...



News published on 22 september 2019 at 03:00 and distributed by: